A detailed history of Sfmg, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Sfmg, LLC holds 2,915 shares of AZN stock, worth $206,790. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,915
Previous 2,815 3.55%
Holding current value
$206,790
Previous $219,000 3.65%
% of portfolio
0.02%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 25, 2024

BUY
$76.67 - $87.62 $7,667 - $8,762
100 Added 3.55%
2,915 $227,000
Q2 2024

Aug 14, 2024

SELL
$66.81 - $80.83 $66,208 - $80,102
-991 Reduced 26.04%
2,815 $219,000
Q1 2024

May 07, 2024

BUY
$61.03 - $69.57 $3,051 - $3,478
50 Added 1.33%
3,806 $257,000
Q4 2023

Jan 30, 2024

SELL
$61.89 - $69.28 $1,052 - $1,177
-17 Reduced 0.45%
3,756 $252,000
Q3 2023

Nov 06, 2023

BUY
$64.85 - $71.7 $1,556 - $1,720
24 Added 0.64%
3,773 $255,000
Q2 2023

Aug 11, 2023

SELL
$69.91 - $75.81 $39,359 - $42,681
-563 Reduced 13.06%
3,749 $268,000
Q1 2023

May 01, 2023

BUY
$63.15 - $71.6 $11,367 - $12,887
180 Added 4.36%
4,312 $299,000
Q4 2022

Jan 25, 2023

SELL
$54.21 - $70.44 $9,486 - $12,327
-175 Reduced 4.06%
4,132 $0
Q3 2022

Oct 20, 2022

BUY
$53.02 - $135.75 $7,581 - $19,412
143 Added 3.43%
4,307 $237,000
Q1 2022

Apr 21, 2022

SELL
$55.72 - $67.12 $16,994 - $20,471
-305 Reduced 6.82%
4,164 $276,000
Q4 2021

Jan 31, 2022

SELL
$54.02 - $63.83 $101,341 - $119,745
-1,876 Reduced 29.57%
4,469 $260,000
Q3 2021

Nov 01, 2021

BUY
$55.56 - $60.79 $75,228 - $82,309
1,354 Added 27.13%
6,345 $381,000
Q1 2021

May 03, 2021

SELL
$47.16 - $54.44 $30,135 - $34,787
-639 Reduced 11.35%
4,991 $248,000
Q4 2020

Feb 02, 2021

BUY
$48.52 - $58.02 $27,025 - $32,317
557 Added 10.98%
5,630 $281,000
Q3 2020

Nov 12, 2020

BUY
$53.07 - $61.1 $63,524 - $73,136
1,197 Added 30.88%
5,073 $278,000
Q2 2020

Aug 03, 2020

BUY
$43.1 - $55.31 $167,055 - $214,381
3,876 New
3,876 $205,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $220B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Sfmg, LLC Portfolio

Follow Sfmg, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sfmg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sfmg, LLC with notifications on news.